Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Agmon-Levin

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Annals of the Rheumatic Diseases|August 16, 2019
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesVictoria Furer, Christien Rondaan, Marloes W Heijstek, et al.
Plos One|January 30, 2014
Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypesZehava Grossman, Jonathan M Schapiro, Itzchak Levy, et al.
Journal of Autoimmunity|April 10, 2009
Prevalence of hepatitis C serum antibody in autoimmune diseasesNancy Agmon-Levin, Maya Ram, Ori Barzilai, et al.
Clinical Pharmacology and Therapeutics|September 20, 2017
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered QuestionnairesNathalie Costedoat-Chalumeau, Frédéric Houssiau, Peter Izmirly, et al.
Clinical Pharmacology and Therapeutics|August 7, 2018
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered QuestionnairesNathalie Costedoat-Chalumeau, Frédéric Houssiau, Peter Izmirly, et al.
Frontiers in Immunology|March 30, 2023
A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinationsFadi Kharouf, Tali Eviatar, Maya Braun, et al.
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
Annals of the Rheumatic Diseases|October 16, 2013
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodiesNancy Agmon-Levin, Jan Damoiseaux, Cees Kallenberg, et al.
Annals of the Rheumatic Diseases|December 6, 2025
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatmentNancy Agmon-Levin, Stanislav Ignatenko, Alexander Gordienko, et al.
Pediatric Dermatology|September 11, 2015
Consensus Communication on Early Peanut Introduction and Prevention of Peanut Allergy in High-Risk InfantsDavid M Fleischer, Scott Sicherer, Matthew Greenhawt, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Annals of the Rheumatic Diseases|August 16, 2019
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesVictoria Furer, Christien Rondaan, Marloes W Heijstek, et al.
Plos One|January 30, 2014
Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypesZehava Grossman, Jonathan M Schapiro, Itzchak Levy, et al.
Journal of Autoimmunity|April 10, 2009
Prevalence of hepatitis C serum antibody in autoimmune diseasesNancy Agmon-Levin, Maya Ram, Ori Barzilai, et al.
Clinical Pharmacology and Therapeutics|September 20, 2017
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered QuestionnairesNathalie Costedoat-Chalumeau, Frédéric Houssiau, Peter Izmirly, et al.
Clinical Pharmacology and Therapeutics|August 7, 2018
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered QuestionnairesNathalie Costedoat-Chalumeau, Frédéric Houssiau, Peter Izmirly, et al.
Frontiers in Immunology|March 30, 2023
A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinationsFadi Kharouf, Tali Eviatar, Maya Braun, et al.
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
Annals of the Rheumatic Diseases|October 16, 2013
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodiesNancy Agmon-Levin, Jan Damoiseaux, Cees Kallenberg, et al.
Annals of the Rheumatic Diseases|December 6, 2025
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatmentNancy Agmon-Levin, Stanislav Ignatenko, Alexander Gordienko, et al.
Pediatric Dermatology|September 11, 2015
Consensus Communication on Early Peanut Introduction and Prevention of Peanut Allergy in High-Risk InfantsDavid M Fleischer, Scott Sicherer, Matthew Greenhawt, et al.
Pageof 20